Syringe Export Market Intelligence: India's 291 Suppliers Shipping to 154 Countries — TransData Nexus 2026

Q: Who are the top syringe exporters from India?

The top syringe exporters from India are: 1. GLAND PHARMA LTD — $62.4M (34.7% market share); 2. GLAND PHARMA LIMITED — $33.1M (18.4% market share); 3. INDIAN IMMUNOLOGICALS LIMITED — $28.5M (15.8% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $23.0M (12.8% market share); 5. MYLAN LABORATORIES LIMITED — $5.2M (2.9% market share). Together they account for 84.6% of India's total syringe export value.

Q: What is the total export value of syringe from India?

The total export value of syringe from India is $179.9M USD, recorded across 3,522 shipment transactions from 291 active exporters to 154 destination countries. The average shipment value is $51.1K.

Q: Which countries import syringe from India?

India exports syringe to 154 countries worldwide. The top importing countries are: UNITED STATES (36.7% share, $66.1M), BELGIUM (14.1% share, $25.4M), SAUDI ARABIA (8.9% share, $16.1M), PHILIPPINES (6.2% share, $11.2M), TURKEY (6.0% share, $10.8M). These five markets account for 72.0% of total export value.

Q: What is the HS code for syringe exports from India?

The primary HS code for syringe exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of syringe exports from India?

The average unit price for syringe exports from India is $19.21 USD per unit, with prices ranging from $0.00 to $1680.17 depending on formulation, packaging, and order volume. The total market is valued at $179.9M across 3,522 shipments.

Q: Which ports handle syringe exports from India?

The primary ports for syringe exports from India are HYDERABAD ICD (12.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.2% of shipments), SAHAR AIR (8.0% of shipments), AHEMDABAD AIR (6.2% of shipments), AHEMDABAD AIR ACC (INAMD4) (5.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of syringe?

India is one of the world's leading exporters of syringe due to its large base of 291 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports syringe to 154 countries, demonstrating 79% global market coverage.

Q: What certifications do Indian syringe exporters need?

Indian syringe exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import syringe from India?

There are 751 registered buyers importing syringe from India, spread across 154 countries. The repeat buyer rate is 57.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top syringe supplier from India?

GLAND PHARMA LTD is the leading syringe exporter from India with a market share of 34.7% and total export value of $62.4M across 619 shipments. The top 5 suppliers together control 84.6% of total export value.

Suresh Sormare

Syringe

India Pharmaceutical Trade Intelligence

$179.9M291 Suppliers154 CountriesHS 30049099

ExportsIndia → UNITED STATES36.7%India → BELGIUM14.1%

#1 Buyer: FRESENIUS KABI

Syringe Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Syringe to the World

Between 2022 and 2026, India exported $179.9M worth of syringe across 3,522 verified shipments to 154 countries — covering 79% of world markets in the Medical Devices & Diagnostics segment. The largest destination is UNITED STATES (36.7%). GLAND PHARMA LTD leads with a 34.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Syringe export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Syringe export data snapshot — $179.9M · 291 exporters · 154 countriesTransData Nexus · Indian Customs Data

Top Syringe Exporters from India

291 active exporters · Ranked by export value

View all 291 →

Top Syringe Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	GLAND PHARMA LTD	$62.4M	619	22	34.7%
2	GLAND PHARMA LIMITED

Top Countries Importing Syringe from India

154 destination markets · Ranked by import value

All 154 countries →

Top Countries Importing Syringe from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$66.1M	36.7%
2	BELGIUM	$25.4M	14.1%
3	SAUDI ARABIA	$16.1M	8.9%
4	PHILIPPINES	$11.2M	6.2%
5	TURKEY	$10.8M	6.0%
6	VIETNAM	$7.0M	3.9%
7	DJIBOUTI	$4.8M	2.7%
8	RUSSIA	$4.4M	2.5%
9	SRI LANKA	$4.4M	2.4%
10	PERU	$3.4M	1.9%

UNITED STATES is India's largest syringe export destination, absorbing 36.7% of total exports worth $66.1M. The top 5 importing countries — UNITED STATES, BELGIUM, SAUDI ARABIA, PHILIPPINES, TURKEY — together account for 72.0% of India's total syringe export value. The remaining 149 destination countries collectively receive the other 28.0%, indicating a well-diversified global distribution network spanning all major continents.

Regulatory Landscape — Syringe

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

The U.S. Food and Drug Administration (FDA) maintains the Orange Book, which lists approved drug products and their therapeutic equivalence evaluations. As of March 2026, the Orange Book includes several approved Abbreviated New Drug Applications (ANDAs) for pre-filled syringes containing various medications. For instance, the FDA has approved ANDAs for pre-filled syringes delivering drugs such as enoxaparin sodium and adalimumab. These approvals indicate a well-established regulatory pathway for generic pre-filled syringes in the U.S. market.

Indian pharmaceutical companies have been active in this domain, with 291 exporters contributing to a total export value of $179.9 million USD for syringes (HS Code: 30049099) between 2022 and 2026. The United States emerged as the primary destination, accounting for 36.7% of these exports. This substantial market share underscores the importance of adhering to FDA regulations, including compliance with Current Good Manufacturing Practices (cGMP) and the submission of comprehensive ANDAs.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), pre-filled syringes are regulated as combination products, encompassing both the medicinal product and the device component. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) require a Marketing Authorization (MA) for such products. Applicants must demonstrate compliance with EU Good Manufacturing Practice (GMP) guidelines, which include stringent quality control measures for both the drug substance and the device.

Recent regulatory actions highlight the importance of device compatibility and safety. In January 2026, the MHRA issued a Class 2 Medicines Recall for Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes due to Good Manufacturing Practice deficiencies cited during a recent inspection at the finished product manufacturing site. (cpe.org.uk) Such incidents underscore the necessity for exporters to ensure that their products meet all regulatory requirements to maintain market access.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) includes certain medications administered via pre-filled syringes in its Model List of Essential Medicines, recognizing their importance in global health. While the WHO Prequalification Programme primarily focuses on medicines, it also assesses the quality of medical devices, including syringes, to ensure they meet international standards.

Pre-filled syringes must comply with pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). These standards specify requirements for the drug substance, formulation, and device components, ensuring product quality and safety.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organization (CDSCO) classifies pre-filled syringes based on their contents. For instance, if the syringe contains a Schedule H drug, it is subject to prescription-only regulations. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), may set ceiling prices for certain medications; however, as of March 2026, specific ceiling prices for pre-filled syringes are not listed.

Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceuticals, ensuring compliance with national regulations and facilitating international trade.

5Patent & Exclusivity Status

The patent landscape for pre-filled syringes varies depending on the drug substance and device technology. While some pre-filled syringes are protected by patents covering the formulation or delivery mechanism, others may be off-patent, allowing for generic competition. Exporters should conduct thorough patent searches to assess the risk of infringement and identify opportunities for market entry.

6Recent Industry Developments

In January 2026, the MHRA issued a Class 2 Medicines Recall for Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes due to Good Manufacturing Practice deficiencies cited during a recent inspection at the finished product manufacturing site. (cpe.org.uk)

In August 2015, the MHRA issued a medical device alert for Medicina Ltd's automatically retracting safety syringes, including insulin syringes, due to risks of needle stick injury and incorrect shelf life information. (diabetes.org.uk)

These developments underscore the importance of stringent quality control and regulatory compliance for manufacturers and exporters of pre-filled syringes.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Syringe

Retail & reference prices across 9 markets vs. India FOB export price of $19.21/unit

Global Price Benchmark for Syringe across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA, syringes are classified as Class II medical devices, subject to specific regulatory controls to ensure safety and effectiveness.
United Kingdom	$0.11	GBP	The NHS Drug Tariff sets the reimbursement price for syringes, ensuring standardized pricing across the healthcare system.
Germany	$0.10	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates medical devices, including syringes, ensuring compliance with EU standards.
Australia

Supply Chain Risk Assessment — Syringe

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including syringe manufacturing, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of these critical components are sourced from China, underscoring a significant dependency. This reliance exposes the supply chain to vulnerabilities stemming from geopolitical tensions, trade restrictions, or production disruptions in China.

To mitigate this risk, the Indian government initiated the Production Linked Incentive (PLI) scheme in October 2024, aiming to bolster domestic production of essential APIs and KSMs. By November 2024, two greenfield plants were inaugurated under this scheme to manufacture key molecules like Penicillin G and Clavulanic Acid, marking a strategic move to reduce import dependence. However, the full impact of these initiatives on reducing dependency remains to be seen, as establishing self-sufficiency in API production is a long-term endeavor.

2Supplier Concentration & Single-Source Risk

The export data for syringes from India reveals a high supplier concentration, with the top five exporters accounting for 84.6% of the total export value. Notably, GLAND PHARMA LTD alone contributes 34.7% of exports, indicating a significant reliance on a limited number of suppliers. Such concentration poses a risk of supply disruptions if any of these key players face operational challenges.

Access Complete Syringe Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,522 transactions across 154 markets.

Request Demo View Pricing

Frequently Asked Questions — Syringe Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top syringe exporters from India?

The leading syringe exporters from India are GLAND PHARMA LTD, GLAND PHARMA LIMITED, INDIAN IMMUNOLOGICALS LIMITED, and 12 others. GLAND PHARMA LTD leads with 34.7% market share ($62.4M). The top 5 suppliers together control 84.6% of total export value.

What is the total export value of syringe from India?

The total export value of syringe from India is $179.9M, recorded across 3,522 shipments from 291 active exporters to 154 countries. The average shipment value is $51.1K.

Which countries import syringe from India?

India exports syringe to 154 countries. The top importing countries are UNITED STATES (36.7%), BELGIUM (14.1%), SAUDI ARABIA (8.9%), PHILIPPINES (6.2%), TURKEY (6.0%), which together account for 72.0% of total export value.

What is the HS code for syringe exports from India?

The primary HS code for syringe exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Syringe

Syringe

How India Exports Syringe to the World

Top Syringe Exporters from India

Top Countries Importing Syringe from India

Quick Facts

Related Medical Devices & Diagnostics

Related Analysis

Need Details?

Regulatory Landscape — Syringe

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Syringe

Supply Chain Risk Assessment — Syringe

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Syringe Trade Intelligence

Frequently Asked Questions — Syringe Exports from India

Who are the top syringe exporters from India?

What is the total export value of syringe from India?

Which countries import syringe from India?

What is the HS code for syringe exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of syringe exports from India?

Which ports handle syringe exports from India?

Why is India a leading exporter of syringe?

What certifications do Indian syringe exporters need?

How many buyers import syringe from India?

What is the market share of the top syringe exporter from India?

Analysis Methodology